Cancer Patients to See More Precise Oncology Treatment via Innovative Life Sciences Coalition

Thomson Reuters, PathGroup and GenoSpace collaborate to deliver advanced personalized medicine assays and reports to oncologists

PHILADELPHIA, (August 13, 2013)GenoSpace, PathGroup and the IP & Science business of Thomson Reuters today announced an innovative initiative to develop and deliver a best-in-class personalized medicine service in oncology, the result of which will enable physicians to make more precise therapeutic recommendations for cancer patients.

Click Here to read the full article.